why choose us

First received: April 06, 2023

Clinical Trial: Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hidradenitis Suppurativa

Study Type: INTERVENTIONAL


Official Title: Randomised, Double-blind, Placebo-controlled, Phase IIb/Phase III Study to Evaluate the Efficacy and Safety of Spesolimab in Patients With Moderate to Severe Hidradenitis Suppurativa. Lunsayil 1.

Brief Summary: This study is open to adults with moderate to severe hidradenitis suppurativa (HS).The purpose of this study is to find out whether a medicine called spesolimab helps people with HS.People who have previously taken specific medicines such as immunosuppressive biologics other than Tumor necrosis factor (TNF) inhibitors cannot take part.This study has 2 parts.In Part 1, participants are divided into 4 groups of almost equal size.3 groups get different doses of spesolimab, 1 group gets placebo.All participants get…

Read more